50 year trails of Nichi-Iko
Fortunately,Nichi-Iko marked 50th anniversary on July 15 , 2015.
In commemoration of it, we made the movie to get you to feel Nichi-Iko's trails until now and challenges to the future.
|1965||Nihon Iyakuhin Kogyo Co., Ltd. established|
|1967||Completed the plant to produce pharmaceutical tablets and powder in Toyama City, followed by the completion of the plant to produce injection drugs.|
|1970||Completed Namerikawa Plant in Namerikawa City|
|1972||Completed Research Institute on Toyama Plant premises|
|1974||Completed Head Office Building in Sogawa, Toyama City|
|1980||Listed on Nagoya Stock Exchange, Second mp4|
|1981||Listed on Osaka Stock Exchange, Second mp4|
|1983||Completed new GLP-compliant Research Institute adjacent to Namerikawa Plant|
|1985||Established Tokyo Branch Office Building in Bunkyo Ward, Tokyo|
|1986||Completed Fukuno Plant (now Nanto) in Fukunomachi, Higashi Tonamigun, Toyama Prefecture|
|1987||Launched SEDAPAIN Injection as new proprietary drug, a central nervous system analgesic|
|1993||Launched CADEX, a drug to treat pressure ulcer and skin ulcer under foreign license was obtained|
|1994||LaucnchedUNICON Tablets, a drug to treat asthma diseases under foreign license|
|1995||Established Head Office Annex as the 30th anniversary of company's foundation|
|1996||Completed revised GMP-compliant injection plant in Yasuda, Namerikawa City|
|1997||Adopted new GPMSP-compliant corporate framework|
|1998||Adopted new GCP-compliant corporate framework|
|2000||Established MPS (Medical Practice Support) team at all business offices|
|2001||Made partially acquisition of OTC business from Japan Tobacco, Inc.
Launched FERRUM Capsules, slow-release iron preparation for oral use and synthetic penicillin PENGOOD as Branded Generic Drug.
|2003||Completed Nichi-Iko Distribution Center in Namerikawa City
Launched FESIN Injection, iron preparation for I.V. use as Branded Generic Drug.
|2004||Installed new sales support system in the Sales Division.
Acquired the sales operation right of Maruko Pharmaceutical Co., Ltd.
|2005||Merged Nihon-Gallen Co., Ltd.
Acquired partially the stock of Maruko Pharmaceutical Co., Ltd., who was subsequently the subsidiary of Nichi-Iko Pharmaceutical Co., Ltd.
Changed the company name to Nichi-Iko Co., Ltd.(the official registered name in English :Nichi-Iko Pharmaceutical Co., Ltd.)
Acquired partially the stock of Oriental Pharmaceutical Co., Ltd., who was subsequently the subsidiary of Nichi-Iko Pharmaceutical Co., Ltd.
|2006||Completed Pharmaceutical Development Center adjacent to Namerikawa Plant
Commenced the operation of Higashi-Nihon Distribution Center
Promoted to First mp4 of both Osaka Stock Exchange and Nagoya Stock Exchange
|2007||Merged with Maruko Pharmaceutical Co., Ltd. to be the wholly owned subsidiary of Nichi-Iko Pharmaceutical Co., Ltd.
Dissolved Kobayashi Yakugaku Industry Co., Ltd., one of the subsidiary of Nichi-Iko Pharmaceutical Co., Ltd.
|2008||Merged and Aquired Teikoku Medix Co., Ltd., to be wholly owned subisidiary of Nichi-iko Pharmaceutical Co., Ltd.|
|2009||Maruko Pharmaceutical Co., Ltd., Oriental Pharmaceutical Co., Ltd., and Teikoku Medix Co., Ltd. were consolidated to create Nichi-iko Pharma Factory Co., Ltd.
Active Pharma Co., Ltd., a manufacturer of Apls for generics, was created as a joint venture company with Mitani Sangyo Co., Ltd.
|2010||Remodeled flagship plant "Pentagon" in Namerikawa city, Toyama started full operation.
Established sanofi-aventis Nichi-Iko K.K. by joint capital investment with sanofi-aventis Group (Currently SANOFI)
Entered into Full Agency Agreement regarding marketing, sales, distribution and logistics in Hong Kong, Thailand and Malayshia with DKSH.
Entered into a capital and business alliance agreement with Aprogen Inc. for research and development of biosimilar products. Listed on the Tokyo Stock Exchange, First mp4.
|2011||Establishment of Nichi-Iko Medical Practice Institute Co., Ltd.
Completed Global Development center, Honeycomb building. Delisting from Osaka Stock Exchange and Nagoya Stock Exchange
|2012||Announced the 6th Medium term business plan "Pyramid"
Acquired Yakuhan Pharmaceutical Co., Ltd.
Merger consolidated subsidiary, Nichi-Iko Pharmaceutical Co., Ltd.
Tokyo office became another head quarter and Namerikawa Plant 1& 2 renamed Toyama Plant 1& 2.
|2013||Completed 2nd flagship plant "Pyramid" in Namerikawa city.
Merged and Aquired Yakuhan Pharmaceutical Co., Ltd., to be wholly owned subisidiary of Nichi-iko Pharmaceutical Co., Ltd.
Established Nichi-Iko Bangkok Representative Office in Thailand
Entered into a business alliance with Biolab in Thailand
Entered into a basic agreement for business acquisition of Astellas Pharma Group, Fuji Plant
Entered into an agreement for capital alliance with Binex in Korea
Entered into a business alliance with Hanoi Pharma in Vietnam
Issued the Commitment-type Rights Offering (Allotment of Listing-type Stock Acquisition Rights without Contribution)
|2014||Established Nichi-Iko (Thailand) Co., Ltd. as a 100% owned local subsidiary in Thailand
Established NIXS Corporation as a 100% owned local subsidiary in USA
Launched Nichi-Iko Pharma Tech Co., Ltd. as a consolidated subsidiary
|2015||Entered into a business alliance with Bangkok Lab and Cosmetic in Thailand|
|2016||Announced the 7th Medium term business plan "Obelisk"
Acquired all outstanding stocks of Sagent Pharmaceuticals, Inc.and made it a wholly owned subsidiary.
|2017||Obtained Marketing Approval for infliximab BS for I.V.Infusion 100mg "Nichi-Iko"
Merger consolidated subsidiary, Nichi-Iko Pharma Tech Co., Ltd.
|12/13/2017||Completion of the new formulation facility “Obelisk Building” construction at the site of the Toyama Plant 1.|
|01/15/2018||Business alliance agreement with Lloyd Laboratories Inc. and Innogen Pharmaceuticals Inc. (Philippines)|
|03/28/2018||Strategic alliance agreement with Eisai Co., Ltd.|
|07/09/2018||Business alliance with Sunward Pharmaceutical Pte Ltd. (Singapore)|